CeQur Raises $29.6 Million
CeQur SA, a Swiss developer of insulin delivery systems for the management of Type II diabetes, has raised $29.6 million in Series A funding. Backers include BMC Ventures, Endeavour Vision, Schroder & Co Bank and Venture Incubator.
6 January 2010•2 mins read
